May 6, 2025
Caissa Troutman, MD, recently treated a patient in her early 50s who she planned to prescribe the anti-obesity medication Zepbound. The patient’s insurance covered Zepbound but […]
May 5, 2025
Predicting a person’s glycemic response to a meal or snack is a key part of the successful management of both type 1 (T1D) and type 2 […]
May 5, 2025
TOPLINE: BRCA1-associated protein 1 (BAP1) was found to inhibit the browning of white adipose tissue in response to cold exposure in mice, offering a potential new […]
May 5, 2025
TOPLINE: Nationally representative survey data reveals that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity treatment more than tripled among US adults without diabetes […]
May 2, 2025
The understanding of fat has evolved in recent decades. Once regarded as nothing more than passive storage reservoirs for fat, adipocytes are now recognized as critical […]
May 2, 2025
An international expert panel has recently released a comprehensive set of recommendations for optimal insulin injection techniques and equipment. The group, called the Forum for Injection […]
May 2, 2025
The use of glucagon-like peptide 1 (GLP-1) medications amongst women – particularly those of childbearing age – has risen dramatically in recent years. From 2020 to […]
May 1, 2025
LONDON (Reuters) -The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first time, a memo […]
April 30, 2025
The European Medicines Agency (EMA) has recommended marketing authorization for Tepezza (teprotumumab) for adults with moderate to severe thyroid eye disease (TED). TED is a rare […]